Todd D Levine
Overview
Explore the profile of Todd D Levine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Machado P, McDermott M, Blaettler T, Sundgreen C, Amato A, Ciafaloni E, et al.
Lancet Neurol
. 2023 Sep;
22(10):900-911.
PMID: 37739573
Background: Inclusion body myositis is the most common progressive muscle wasting disease in people older than 50 years, with no effective drug treatment. Arimoclomol is an oral co-inducer of the...
2.
Gibbons C, Rajan S, Senechal K, Hendry E, McCallister B, Levine T
Muscle Nerve
. 2023 Apr;
67(6):E26-E27.
PMID: 37043644
No abstract available.
3.
Gibbons C, Rajan S, Senechal K, Hendry E, McCallister B, Levine T
Muscle Nerve
. 2022 Nov;
67(5):363-370.
PMID: 36367813
Introduction/aims: Small fiber neuropathies (SFN) have been associated with two autoantibodies, trisulfated heparin disaccharide (TS-HDS) and fibroblast growth factor receptor 3 (FGFR-3), and intravenous immune globulin (IVIG) has been suggested...
4.
Evidente V, Evidente D, Ortega S, Levine T, Freeman R, Gibbons C
Mov Disord
. 2021 Sep;
37(1):130-136.
PMID: 34582053
Background: X-linked dystonia parkinsonism (XDP) or "Lubag" is a genetic dystonia syndrome observed among Filipinos that can present with levodopa-responsive parkinsonism and abnormal dopamine transporter (DAT) imaging. Objective: The aim...
5.
Levine T, Bellaire B, Gibbons C, Freeman R
Ann Clin Transl Neurol
. 2021 Mar;
8(4):908-917.
PMID: 33764697
Objective: To report a case series of patients with neuropathic POTS and cutaneous phosphorylated alpha-synuclein (P-SYN) deposition on skin biopsy and compare these to neuropathic POTS patients without P-SYN deposition....
6.
Levine T, Kafaie J, Zeidman L, Saperstein D, Massaquoi R, Bland R, et al.
Muscle Nerve
. 2019 Oct;
61(4):512-515.
PMID: 31650561
Introduction: Causes of small-fiber peripheral neuropathies (SFN) are often undefined. In this study we investigated associations of serum autoantibodies, immunoglobulin G (IgG) vs fibroblast growth factor receptor-3 (FGFR-3), and immunoglobulin...
7.
Levine T
Am J Case Rep
. 2019 Jul;
20:965-970.
PMID: 31278249
BACKGROUND Eculizumab is a terminal complement inhibitor used to treat myasthenia gravis in patients refractory (because of insufficient efficacy or intolerance) to other therapies, including intravenous immunoglobulin. However, information is...
8.
Levine T, Katz J, Barohn R, Vaughan L, Dimachkie M, Saperstein D, et al.
Neurol Clin Pract
. 2018 Dec;
8(5):429-436.
PMID: 30564497
Background: This project is an effort to understand how orders for IV immunoglobulin (IVIg) are documented and prescribed by physicians, and subsequently, how they are reviewed by insurance companies for...
9.
Rodriguez-Leyva I, Chi-Ahumada E, Mejia M, Castanedo-Cazares J, Eng W, Saikaly S, et al.
Mov Disord Clin Pract
. 2018 Oct;
4(5):724-732.
PMID: 30363411
Background: The misfolding and prion-like propagation of the protein α-synuclein (α-syn) is the leading molecular signature in Parkinson's disease (PD). There is a significant coincidence of PD and melanoma that...
10.
Levine T
J Cent Nerv Syst Dis
. 2018 May;
10:1179573518771703.
PMID: 29706768
Small fiber neuropathy (SFN) has a poorly understood pathology, but patients would benefit from determination of clinical phenotypes that allows for better diagnosis and treatment planning. I propose that patients...